Invasive candidiasis in neonatal intensive care unit;Candidoses invasives en réanimation néonatale

Archives de Pediatrie

Volumn 18, Issue SUPPL. 1, 2011, Pages

  Brissaud, O ^a   Tandonnet, O ^a   Guichoux, J ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ARTICLE; BIRTH WEIGHT; CATHETER INFECTION; DISEASE SEVERITY; FRANCE; FUNGAL COLONIZATION; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INCIDENCE; INVASIVE CANDIDIASIS; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREMATURITY; RISK FACTOR;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDIASIS, INVASIVE; CATHETERS; FLUCONAZOLE; FRANCE; HUMANS; INCIDENCE; INFANT; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE, NEONATAL; RISK FACTORS; TREATMENT OUTCOME;

EID: 79956049851     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/S0929-693X(11)70937-X     Document Type: Article

References (29)

1. Mahieu L.M., Van Gasse N., Wildemeersch D., et al. Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient. Pediatr Crit Care Med 2010, 11:240-245.
2. Benjamin D.K., Stoll B.J., Gantz M.G., et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010, 126:e865-e873.
3. Kaufman D.A. Neonatal candidiasis: clinical manifestations, management and prevention strategies. J Pediatr 2010, 156:S53-S67.
4. Brendel C.M. Candidiasis. Infectious diseases of the fetus and newborn infants 2006, Elsevier Saunders. Sixth Ed. Remington, W.B. Klein (Eds.).
5. Chapman R.L. Prevention and treatment of Candida infections in neonates. Semin Perinatol 2007, 31:39-46.
6. Smith P.B., Steinbach W.J., Benjamin D.K. Neonatal candidiasis. Infect Dis Clin North Am 2005, 19:603-615.
7. Lee B.E., Cheung P.Y., Robinson J.L., et al. Comparative study of mortality and morbidity in premature infants (birth weight, < 1,250g) with candidemia or candidal meningitis. Clin Infect Dis 1998, 27:559-565.
8. Friedman S., Richardson S.E., Jacobs S.E., et al. Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J 2000, 19:499-504.
9. Aujard Y., Farnoux C., Lefevre S., et al. Infections néonatales à Candida. Arch Pediatr 2003, 10:569s-574s.
10. Hot A. Infections fongiques invasives du grand prématuré. J Mycol Med 2007, 17:33-41.
11. Noyola D.E., Fernandez M., Moylett E.H., et al. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 2001, 32:1018-1023.
12. Benjamin D.K., Stoll B.J., Fanaroff A.A., et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006, 117:84-92.
13. Moylett E.H. Neonatal Candida meningitis. Semin Pediatr Infect Dis 2003, 14:115-122.
14. Gordon P.V. Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr Res 2009, 65:138-144.
15. Arendrup M.C., Fisher B.T., Zaoutis T.E. Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues. Clin Microbiol Infect 2009, 15:613-624.
16. Kaufman D.A. Challenging issues in neonatal candidiasis. Curr Med Res Opin 2010, 26:1769-1778.
17. Kaufman D.A., Manzoni P. Strategies to prevent invasive candidal infection in extremely preterm infants. Clin Perinatol 2010, 37:611-628.
18. Pappas P.G., Kauffman C.A., Andes D., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
19. Blyth M.L., Hale K., Palasanthiran P., et al. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections. Cochrane Database Syst Rev 2010, CD006343.
20. Zaoutis T., Walsh T.J. Antifungal therapy for neonatal candidiasis. Curr Opin Infect Dis 2007, 20:592-597.
21. Manzoni P., Rizzollo S., Franco C., et al. Role of echinocandins in the management of fungal infections in neonates. J Matern Fetal Neonatal Med 2010, 23:49-52.
22. Hope W.W., Smith P.B., Arrieta A., et al. Population pharmacokinetics of micafungin in neonates and young infants. Antimicrob Agents Chemother 2010, 54:2633-2637.
23. Saez-Llorens X., Macias M., Maiya P., et al. Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age. Antimicrob Agents Chemother 2009, 53:869-875.
24. Aziz M., Patel A.L., Losavio J., et al. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants. Pediatr Infect Dis J 2010, 29:352-356.
25. Kaufman D., Boyle R., Hazen K.C., et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001, 345:1660-1666.
26. Manzoni P., Stolfi I., Pugni L., et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007, 356:2483-2495.
27. Manzoni P., Leonessa M., Galletto P., et al. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr Infect Dis J 2008, 27:731-737.
28. Poikonen E., Lyytikainen O., Anttila V.J., et al. Secular trend in Candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 2010, 10:312.
29. Roilides E., Farmaki E., Evdoridou J., et al. Neonatal candidiasis:analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 2004, 23:745-750.